author-photo

Jing Yang

Kōchi University

60

Papers

1508

Citations

Citation Trend

Filter By

Papers (41) Sort By

Journal Conference Others

miR-217 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitors by targeting pro-oncogenic anterior gradient 2

2018 Experimental Hematology
Show All
- Source
- Cite
- Save
Citations (12)
Thrombomodulin alleviates murine GVHD in association with an increase in the proportion of regulatory T cells in the spleen

2015 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (20)
STAT5A regulates DNMT3A in CD34+/CD38− AML cells

2015 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (12)
Abstract 1717: Downregulation of miR-217 correlates with resistance of ph+ leukemia cells to ABL tyrosine kinase inhibitors

2014 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Downregulation of miR‐217 correlates with resistance of ph+ leukemia cells to ABL tyrosine kinase inhibitors

2014 Cancer Science
Show All
- Source
- Cite
- Save
Citations (49)
Bcr‐Abl activates AURKA and AURKB in chronic myeloid leukemia cells via AKT signaling

2014 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (26)
The Fifth Region of Epidermal Growth Factor like-Domain of Thrombomodulin Is Essential to Produce Cytoprotection

2014 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 5599: A novel treatment strategy targeting shugoshin 1 in hematological malignancies.

2013 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 2030: Inhibition of IRE1α-XBP1 pathway is a promising therapeutic application in acute myeloid leukemia.

2013 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
A novel treatment strategy targeting shugoshin 1 in hematological malignancies

2013 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (9)